trial · primary record
AZD0120
Systemic Sclerosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 27 |
| Primary completion | 2028-02-22 |
| Primary endpoint | Number of participants and severity of dose limiting toxicities (DLTs) and treatment-emergent adverse events (TEAEs) |
| Registry ID | NCT07295847 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:05.611Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07295847
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.